Metropolitan Life Insurance CO Protagonist Therapeutics, Inc Transaction History

Metropolitan Life Insurance CO

$281 Million
Q3 2024

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$21.79 - $32.15 $6,863 - $10,127	-315 Reduced 9.4%	3,037 $87,000
Q3 2023 Nov 14, 2023	BUY	$16.68 - $23.66 $6,488 - $9,203	389 Added 13.13%	3,352 $55,000
Q2 2023 Aug 10, 2023	BUY	$18.02 - $29.36 $7,982 - $13,006	443 Added 17.58%	2,963 $81,000
Q1 2023 May 15, 2023	SELL	$10.78 - $25.38 $4,322 - $10,177	-401 Reduced 13.73%	2,520 $57,000
Q4 2022 Jun 14, 2023	BUY	$7.36 - $11.17 $2,951 - $4,479	401 Added 15.91%	2,921 $31.9 Million
Q3 2022 Jun 14, 2023	BUY	$7.86 - $11.71 $3,151 - $4,695	401 Added 15.91%	2,921 $24.6 Million
Q2 2022 Jun 20, 2023	BUY	$7.06 - $25.52 $2,831 - $10,233	401 Added 15.91%	2,921 $23,000
Q1 2022 Jun 20, 2023	BUY	$23.34 - $36.08 $9,359 - $14,468	401 Added 15.91%	2,921 $69,000
Q1 2022 Mar 30, 2023	SELL	$23.34 - $36.08 $205,998 - $318,442	-8,826 Reduced 75.13%	2,921 $69,000
Q1 2022 May 12, 2022	SELL	$23.34 - $36.08 $205,998 - $318,442	-8,826 Reduced 75.13%	2,921 $69,000
Q4 2021 Jun 21, 2023	BUY	$17.63 - $37.1 $162,672 - $342,321	9,227 Added 366.15%	11,747 $401,000
Q3 2021 Jun 21, 2023	BUY	$12.95 - $49.69 $119,489 - $458,489	9,227 Added 366.15%	11,747 $208,000
Q3 2021 Mar 30, 2023	BUY	$12.95 - $49.69 $2,525 - $9,689	195 Added 1.69%	11,747 $208,000
Q3 2021 Nov 15, 2021	BUY	$12.95 - $49.69 $2,525 - $9,689	195 Added 1.69%	11,747 $208,000
Q2 2021 Jun 21, 2023	BUY	$25.57 - $44.88 $230,948 - $405,356	9,032 Added 358.41%	11,552 $518,000
Q2 2021 Mar 30, 2023	BUY	$25.57 - $44.88 $57,992 - $101,787	2,268 Added 24.43%	11,552 $518,000
Q2 2021 Aug 16, 2021	BUY	$25.57 - $44.88 $295,154 - $518,049	11,543 Added 128255.56%	11,552 $518,000
Q1 2021 Jun 26, 2023	BUY	$19.02 - $31.15 $128,651 - $210,698	6,764 Added 268.41%	9,284 $240 Million
Q1 2021 May 14, 2021	SELL	$19.02 - $31.15 $176,410 - $288,916	-9,275 Reduced 99.9%	9 $240,000
Q4 2020 Jun 22, 2023	BUY	$18.49 - $25.13 $125,066 - $169,979	6,764 Added 268.41%	9,284 $187,000
Q3 2020 Jun 26, 2023	BUY	$15.19 - $22.4 $102,745 - $151,513	6,764 Added 268.41%	9,284 $181,000
Q3 2020 Mar 30, 2023	BUY	$15.19 - $22.4 $27,782 - $40,969	1,829 Added 24.53%	9,284 $181,000
Q3 2020 Nov 13, 2020	BUY	$15.19 - $22.4 $27,782 - $40,969	1,829 Added 24.53%	9,284 $182,000
Q2 2020 Jun 26, 2023	BUY	$6.19 - $18.84 $30,547 - $92,975	4,935 Added 195.83%	7,455 $131,000
Q2 2020 Mar 30, 2023	BUY	$6.19 - $18.84 $5,187 - $15,787	838 Added 12.66%	7,455 $131,000
Q2 2020 Aug 14, 2020	BUY	$6.19 - $18.84 $46,146 - $140,452	7,455 New	7,455 $132,000
Q4 2019 Feb 14, 2020	SELL	$4.69 - $13.45 $31,033 - $88,998	-6,617 Closed	0 $0
Q3 2019 Jul 12, 2023	BUY	$9.41 - $16.56 $38,552 - $67,846	4,097 Added 162.58%	6,617 $79,000
Q3 2019 Mar 30, 2023	BUY	$9.41 - $16.56 $34,779 - $61,205	3,696 Added 126.53%	6,617 $79,000
Q3 2019 Nov 14, 2019	BUY	$9.41 - $16.56 $62,265 - $109,577	6,617 New	6,617 $79,000

Others Institutions Holding PTGX

# of Institutions

247

Shares Held

56.4M

Call Options Held

76.3K

Put Options Held

114K

Farallon Capital Management LLC San Francisco, CA

5.86M
Shares

$238 Million
1.32% of portfolio
Black Rock Inc. New York, NY

5.76M
Shares

$234 Million
0.0% of portfolio
Rtw Investments, LP New York, NY

5.43M
Shares

$221 Million
3.89% of portfolio
Vanguard Group Inc Valley Forge, PA

4.22M
Shares

$172 Million
0.0% of portfolio
State Street Corp Boston, MA

3.18M
Shares

$130 Million
0.01% of portfolio

View Full List

About Protagonist Therapeutics, Inc

Ticker PTGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,084,100
Market Cap $2B
Description
Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with...

More about PTGX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Account